A — AGILENT TECHNOLOGIES, INC.
—
NYSE ·
Unknown ·
Unknown ·
CIK 1090872 ·
Last close
$172.22
Market Cap
$48.56B
52W High
$182.99
52W Low
$107.98
ADV30
2,069,676
Next earnings
2026-11-23
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jul 2026 | 1,878,000,000 | 1,042,000,000 | 444,000,000 | 362,000,000 | 13,967,000,000 | 1,758,000,000 | 6,604,000,000 |
| Apr 2026 | 1,835,000,000 | 990,000,000 | 399,000,000 | 339,000,000 | 13,065,000,000 | 1,807,000,000 | 5,943,000,000 |
| Jan 2026 | 1,798,000,000 | 946,000,000 | 353,000,000 | 305,000,000 | 12,813,000,000 | 1,758,000,000 | 5,905,000,000 |
| Oct 2025 | 1,861,000,000 | 990,000,000 | 443,000,000 | 434,000,000 | 12,727,000,000 | 1,789,000,000 | 5,986,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,609,000,000
Investing CF
$-1,292,000,000
Financing CF
$-95,000,000
CapEx
$-342,000,000
Dividends Paid
$-286,000,000
Buybacks
$-380,000,000
EPS Diluted TTM
$5.08
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$1,912,000,000
Inventory
$1,117,000,000
Receivables
$1,478,000,000
ST Investments
—
EBIT TTM
$1,764,000,000
Pretax Income TTM
$1,658,000,000
Interest Exp TTM
$106,000,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$7,372,000,256
EBITDA
$2,080,000,000
Free Cash Flow
$1,060,374,976
Enterprise Value
$43,813,806,080
Total Cash
$1,758,000,000
Total Debt
$4,148,000,000
Shares Out
281,965,813
Trailing EPS
$5.07
Book Value
$26.11
ROE
21.0%
ROA
8.6%
Div Yield
0.69%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Oct 2025 | 6,948,000,000 | 1,479,000,000 | 1,303,000,000 | 12,727,000,000 | 5,986,000,000 | 6,741,000,000 | 1,559,000,000 |
| Oct 2024 | 6,510,000,000 | 1,488,000,000 | 1,289,000,000 | 11,846,000,000 | 5,948,000,000 | 5,898,000,000 | 1,751,000,000 |
| Oct 2023 | 6,833,000,000 | 1,350,000,000 | 1,240,000,000 | 10,763,000,000 | 4,918,000,000 | 5,845,000,000 | 1,772,000,000 |
| Oct 2022 | 6,848,000,000 | 1,618,000,000 | 1,254,000,000 | 10,532,000,000 | 5,227,000,000 | 5,305,000,000 | 1,312,000,000 |
TTM Snapshot
Revenues TTM
$7,372,000,000
NetIncome TTM
$1,440,000,000
OpCashFlow TTM
—
Assets (Latest)
$13,967,000,000
Forward EPS
$6.76
Max Pain — expiry 2027-01-15
max pain strike: $150.00 · spot: $177.33 · call oi: 4,454 · put oi: 2,426
Expected Move to 2027-01-15:
±$21.20
(11.96%) —
implied range
$156.13 –
$198.53
· ATM straddle on $175.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LHX | L3HARRIS TECHNOLOGIES, INC. /DE/ | $48.55B | $260.74 | — |
| KEYS | Keysight Technologies, Inc. | $48.43B | $284.45 | — |
| RBGLY | RECKITT BENCKISER GROUP PLC | $48.14B | $15.19 | — |
| WAB | WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP | $49.05B | $290.41 | — |
| VYLR | Vylor Inc. | $46.85B | $70.21 | — |
News headlines (Yahoo Finance, 1h cache)
Agilent Announces Cash Dividend of 26.25 Cents per Share
2026-11-18 21:15 · Yahoo
Agilent Technologies (A) Surged in Q3 on Strong Reshoring Demand and Equipment Upgrades
2026-11-18 16:14 · Yahoo
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
2026-11-18 16:10 · Yahoo
Agilent (A) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
2026-11-18 13:15 · Yahoo
Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth
2026-11-16 14:00 · Yahoo
Agilent Technologies (A) Launches New Cancer Panel As Valuation Stays In Focus
2026-11-12 22:12 · Yahoo
Agilent to Participate in 9th Annual Evercore Healthcare Conference
2026-11-12 21:15 · Yahoo
Learn Why The Bull Case For Agilent Stock Could Change Following Pan Heme Launch
2026-11-12 17:12 · Yahoo
Agilent Technologies (A) Expands Tumor Profiling With New Pan Heme Research Panel
2026-11-12 06:09 · Yahoo
RNA Analysis / Transcriptomics - Global Strategic Business Report: Capitalize on 13.4% CAGR to $19B by 2030 as Agilent, Beckman Coulter, bioMerieux, BGI Genomics, and 10X Genomics Accelerate
2026-11-11 14:22 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.